3-D mammography increases cancer detection and reduces callback rates

Compared with traditional mammography, 3D mammography—known as digital breast tomosynthesis—found 22% more breast cancers and led to fewer callbacks in a large screening study, as researchers reported at the annual meeting of the Radiological Society of North America (RSNA), which was held December 1-6, 2013, in Chicago, Illinois.

Conventional digital mammography is the most widely used screening modality for breast cancer, but may yield suspicious findings that turn out not to be cancer, known as false-positives. Such findings are associated with a higher recall rate, or the rate at which women are called back for additional imaging or biopsies that may be deemed unnecessary.

Tomosynthesis, however, allows for 3-D reconstruction of the breast tissue, giving radiologists a clearer view of the overlapping slices of breast tissue. Though a relatively new technology, it has shown promise at reducing recall rates in all groups of patients, including younger women and those with dense breast tissue. This study is one of the largest prospective trials in tomosynthesis to date, and was presented by Emily F. Conant, MD, chief of Breast Imaging at the Department of Radiology at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia. The screening study was conducted at the Hospital of the University of Pennsylvania (HUP), also located in Philadelphia.

For the study, the research team compared imaging results from 15,633 women who underwent tomosynthesis at HUP beginning in 2011 with those of 10,753 patients imaged with digital mammography the prior year. Six radiologists trained in tomosynthesis interpretation reviewed the images.

Researchers found that, compared with conventional mammography, the average recall rate using tomosynthesis decreased from 10.40% to 8.78%, and the cancer detection rate increased from 4.28 to 5.24 per 1,000 patients, a 22% increase.

"Our study showed that we reduced our callback rate and increased our cancer detection rate," said Conant, the study's lead author. "The degree to which these rates were affected varied by radiologist. But importantly, the ratio of callback to cancer detection rate improved significantly for our radiologists."

The overall positive predictive value—the proportion of positive screening mammograms from which cancer was diagnosed—increased from 4.1% to 6.0% with tomosynthesis, a 46% increase.

Since October 2011, all screening mammograms at Penn Medicine now include tomosynthesis, according to Conant.

"It's the most exciting improvement to mammography that I have seen in my career, even more important than the conversion from film-screen mammography to digital mammography," she said. "The coming years will be very exciting, as we see further improvements in this innovative technology."

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs